Table_3.xls (9.5 kB)
Determinants for receiving non-invasive ischemia testing before coronary angiography, controlled for high risk patients.
dataset
posted on 2015-02-26, 03:03 authored by Corinne Chmiel, Oliver Reich, Andri Signorell, Ryan Tandjung, Thomas Rosemann, Oliver SennOdds ratio (OR). Lower Confidence Interval (LCI). Upper Confidence Interval (UCI). Coronary Angiography (CA). Anatomical-Therapeutic-Chemical-Classification (ATC) group 1 = Aspirin, platelet aggregation inhibitors, Group 2 = statins, lipid modifying agents, group 3 = antihypertensives, diuretics, beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, group 4 = antidiabetics. Pharmaceutical cost groups (PCG).
°High risk patients: having received therapeutic cardiac intervention within one month after or 18 months prior to diagnostic CA.
*p<0.05.
Determinants for receiving non-invasive ischemia testing before coronary angiography, controlled for high risk patients.
History
Usage metrics
Categories
Keywords
emergency proceduresproportioncare modelDiagnostic Coronary Angiographystress echocardiographycomputer tomographycofactors.ConclusionsOur data showInsurance CoverageCardiac Ischemia TestingNIIT.Findings 2714 patientsrisk patientstransthoracic echocardiographylanguage area2013. Patientscaantiplatelet therapyInpatient Treatment18 monthsregression analysisHigh risk statusinsurance claims dataischemia testingheart MRINIIT procedures
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC